Our Blog
Insights, updates, and technical deep dives from our team of AI scientists and biotech experts
How 20 Amino Acids Shape Antibody Engineering
The chemical logic of 20 amino acids — from hydrophobic cores and salt bridges to π-stacking — and how each category governs CDR design, framework stability, and developability.
Read More
NGS vs Mass Spectrometry for Antibody Sequencing: A Practical Guide
A side-by-side comparison of NGS and mass spectrometry for antibody sequencing — sensitivity, throughput, cost, and when to use each method.
Read More
Anti-PD-1 Antibody Engineering: What 18 Globally Approved Antibodies Reveal About Epitope, Affinity, and Blocking
Why epitope location beats affinity for functional blocking — structural lessons from 22 PD-1 crystal complexes, germline gene convergence across approved drugs, N58 glycan binding, and bispecific platform extension.
Read More
Antibody Downstream Processing: Purification Steps from Harvest to Final Drug Substance
A complete guide to antibody purification — Protein A capture, viral inactivation, ion exchange polishing, viral filtration, and UF/DF — achieving >99% purity at manufacturing scale.
Read More
Biopharmaceutical Manufacturing GMP Checklist for Biotech Startups
What to verify in your CRO partner before committing to clinical-grade antibody manufacturing — facility, quality systems, analytics, and regulatory documentation.
Read More
Stable Cell Line Development Timeline: A Step-by-Step Guide
Every stage from vector construction to working cell bank delivery — with realistic timelines and how CRISPR integration compresses the schedule.
Read More
From mg to kg: Scaling Recombinant Antibody Production Without Losing Quality
A practical guide to upstream and downstream scale-up challenges — oxygen transfer, CO₂ accumulation, glycosylation shifts, and CQA comparability.
Read More
How CRISPR Site-Specific Integration Eliminates Clonal Variability in Stable Cell Lines
Why random integration creates unpredictable CHO clones — and how CRISPR targeting delivers deterministic, high-expressing stable cell lines.
Read More
AI-Designed Antibodies in Human Trials: Evidence Tiers, Case Studies, and What's Next
GB-0669, ABS-101, rentosertib — the first wave of generative AI-designed biologics has reached clinical stage. A rigorous look at the evidence and what it means for antibody engineering.
Read More
AI Antibody Design vs Traditional Hybridoma: A Head-to-Head Comparison
Speed, cost, success rate, and target accessibility compared across AI antibody design and hybridoma technology. When to choose each approach.
Read More
What Is UCOE? How It Prevents Gene Silencing in CHO Expression Systems
How Ubiquitous Chromatin Opening Elements solve the epigenetic silencing problem in CHO stable cell line development — and why UCOE + CRISPR is the gold standard.
Read More
Recombinant Protein Expression: CHO vs HEK293 vs E. coli — Which to Choose
A practical comparison of CHO, HEK293, and E. coli expression systems across yield, glycosylation, scalability, and regulatory acceptability.
Read More
OEM Antibody Manufacturing for IVD: What to Look for in a CRO Partner
How to evaluate OEM antibody manufacturing partners for IVD diagnostics: quality specs, supply reliability, regulatory documentation, and key questions to ask.
Read More
The Future of AI-Driven Antibody Design
Explore how large language models are transforming antibody discovery, enabling faster development of higher-quality therapeutic and diagnostic antibodies.
Read More
CRISPR Site-Specific Integration for Stable Cell Line Development
Learn how targeted integration technology eliminates clonal variability and significantly reduces stable cell line development timelines.
Read More
UCOE Technology: Preventing Epigenetic Silencing in Recombinant Protein Expression
Discover how Universal Chromatin Opening Elements ensure long-term stable expression and higher yields in bioproduction.
Read More
Reducing Antibody Development Costs: A Practical Guide for Biotech Startups
Cost-saving strategies and best practices for antibody development programs, from early-stage research to GMP manufacturing.
Read More
Bispecific Antibodies: Challenges and Advances in Manufacturing
Overcoming the unique challenges of bispecific antibody expression and purification for therapeutic applications.
Read More
CHO Cell Line Engineering: The Foundation of Modern Biomanufacturing
A deep dive into CHO cell biology and the latest advances in cell line engineering for improved bioproduction performance.
Read More